Tag
GSK
Nigeria's transition triumphs amidst challenges as we enter seamlessly a fifth democratic government showing signals of resilience, despite economic and political turmoil, sparking moments of discontent and optimism across the nation.
GSK's announcement to cease direct business operations in Nigeria reflects a significant decision with potential implications for stakeholders, the stock market, and the Nigerian economy.
GSK UK Group has informed GlaxoSmithKline Consumer Nigeria PLC of its strategic intent to cease operations in Nigeria.
The unclaimed dividend of shareholders of GlaxoSmithKline Consumer Nigeria (GSK) Plc as of December 31, 2022, grew to N1.28 billion.
GlaxoSmithKline Consumer Nigeria Plc shareholders N657.73 million as dividends at the rate of 55 kobos per share.
In common with many companies operating in Nigeria, foreign exchange availability continues to impact our operations.
GlaxoSmith Kline Plc released its unaudited financial results for the third quarter of the year ended 30th of...
The Board of Directors of GlaxoSmithKline Consumer Nigeria Plc (GSK), has appointed a new Managing Director (MD).
GlaxoSmithKline Consumer Nigeria Plc's board of directors has disclosed the resignation of Bhushan Akshikar, the Managing Director of the Company and Kareem Hamdy, the Finance Director.